[Expression of osteopontin and survivin in prostate cancer and the clinical significance]
- PMID: 20501415
[Expression of osteopontin and survivin in prostate cancer and the clinical significance]
Abstract
Objective: To determine the expression of osteopontin (OPN) and survivin in prostate cancer tissue, and study their correlation and roles in tumor invasion and metastasis.
Methods: The expressions of OPN and survivin in prostate cancer tissue, prostate hyperplasia tissue and normal prostate tissue were determined by RT-PCR and immunohistochemistry.
Results: The positive expression rates of OPN mRNA and protein in prostate cancer tissue [76.1% (35/46) and 69.6% (32/46)] were significantly correlated to survivin expression [67.4% (31/46) and 67.4% (31/46)] (P<0.05). The expressions of OPN and survivin were related to the tumor grade and clinical stages (P<0.05). OPN and survivin were not found in prostate hyperplasia and normal prostate tissues.
Conclusion: OPN and survivin may play important roles in the progression of prostate cancer and can be potential markers for invasion and metastasis of prostate cancer. OPN and survivin might play synergetic roles in prostate carcinogenesis.
Similar articles
-
Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.Exp Mol Pathol. 2012 Feb;92(1):13-9. doi: 10.1016/j.yexmp.2011.09.014. Epub 2011 Sep 22. Exp Mol Pathol. 2012. PMID: 21963599
-
Survivin mRNA-circulating tumor cells are associated with prostate cancer metastasis.Tumour Biol. 2016 Jan;37(1):723-7. doi: 10.1007/s13277-015-3812-5. Epub 2015 Aug 6. Tumour Biol. 2016. Retraction in: Tumour Biol. 2017 Apr 20. doi: 10.1007/s13277-017-5487-6. PMID: 26242261 Retracted.
-
[Protein and mRNA expression of osteopontin in lung cancer and clinical significance thereof].Zhonghua Yi Xue Za Zhi. 2007 Dec 4;87(45):3219-23. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18399118 Chinese.
-
Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysis.Biosci Rep. 2021 Aug 27;41(8):BSR20203531. doi: 10.1042/BSR20203531. Biosci Rep. 2021. PMID: 33635319 Free PMC article.
-
Osteopontin as a multifaceted driver of bone metastasis and drug resistance.Pharmacol Res. 2019 Jun;144:235-244. doi: 10.1016/j.phrs.2019.04.030. Epub 2019 Apr 24. Pharmacol Res. 2019. PMID: 31028902 Review.
Cited by
-
Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection of the prostate or prostatectomy.Springerplus. 2016 May 14;5:621. doi: 10.1186/s40064-016-2283-5. eCollection 2016. Springerplus. 2016. PMID: 27330887 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials